Side Effects of Stopping Zepbound: A Realistic Timeline

If you are stopping Zepbound, or thinking about it, the question that actually matters is not "is there withdrawal" but "what happens to my appetite and my weight now." The short version: tirzepatide does not cause a dangerous chemical withdrawal, so nothing hazardous happens when you stop. What does happen is that the drug's effects fade over several weeks, appetite and food noise return, and, because Zepbound tends to produce larger losses than other GLP-1s, the rebound can be larger in absolute terms too. Here is a realistic timeline of what to expect and how to meet the early window well.

How Zepbound leaves your system

Tirzepatide, the active ingredient in Zepbound, has a mean half-life of about 5 days, slightly shorter than semaglutide's roughly 7 days. Using the standard rule of thumb that a drug is substantially cleared after about five half-lives, tirzepatide takes roughly 4 weeks to largely leave your system after your last injection. That is faster than Wegovy or Ozempic, but the fade is still gradual, not a cliff, which gives you a real runway to prepare.

What comes back, and what does not

There is no chemical dependence with tirzepatide, so nothing about stopping Zepbound puts you at medical risk on its own. What people describe as "Zepbound withdrawal" is the drug's dual GIP/GLP-1 effect wearing off: appetite climbs, food noise returns, and for some people gastrointestinal symptoms that had settled during treatment can shift again as the gut hormone signaling changes. None of this means anything went wrong. It is the return of your physiology once the strongest appetite-suppressing agent in the GLP-1 class is no longer active.

• Appetite returns, often noticeably: because Zepbound suppresses appetite more strongly than semaglutide on average, some people feel the rebound as more dramatic.
• Food noise comes back: the quieted mental chatter about food tends to return over the same few weeks.
• GI symptoms can shift: nausea or reflux that had improved on treatment may fluctuate as gut hormone levels change.
• Weight regain: often begins within the first couple of months, and can be steep given the larger average losses tirzepatide produces.

What the SURMOUNT-4 withdrawal trial actually showed

The clearest picture of stopping tirzepatide comes from SURMOUNT-4. After a 36-week open-label lead-in in which participants lost an average of roughly 21% of body weight, half continued tirzepatide and half were switched to placebo for another 52 weeks. The group that continued lost an additional 5.5%, while the group switched to placebo regained an average of 14 percentage points, roughly two-thirds of the lead-in loss. By the end of the study, the placebo group still held onto about 9.9% total loss versus 25.3% for those who continued. In a more granular look at people who had lost the most weight, 82% of the placebo group regained more than a quarter of their lost weight within a year of stopping. This is the same rebound pattern seen across the GLP-1 class, appetite hormones rebound and metabolic rate stays low, but it lands harder here simply because there is more weight loss to give back. See our broader breakdown in why weight comes back after GLP-1.

The early window and the four pillars

Because tirzepatide clears faster than semaglutide, your window to set up habits before the rebound fully arrives is shorter, about 4 weeks instead of 5. That makes acting early even more valuable. Four pillars have the strongest evidence for protecting your loss: protein to blunt appetite and preserve the muscle you have, given how much lean mass is at stake with larger losses, strength training to keep your metabolism elevated, sleep, and daily movement. Our maintenance guide stitches them into one plan you can run without the pen.

• Protein: around 1.5 g/kg of body weight per day, roughly 25 to 30 g per meal, to stay full on less and protect lean mass. See protecting lean mass on GLP-1.
• Strength training: 2 to 3 sessions a week; larger losses mean more muscle at risk without it.
• Sleep: 7 to 9 hours; short sleep worsens hunger hormones and fat loss.
• Daily movement: extra steps and standing add a steady calorie buffer that returning appetite has to overcome.

The bottom line

Stopping Zepbound does not trigger a dangerous withdrawal. Over about four weeks the drug clears, and what follows is a return of appetite and food noise, larger in absolute terms than with other GLP-1s simply because tirzepatide tends to produce larger losses to begin with. The SURMOUNT-4 data is direct about the stakes: without continuing treatment, most of a lead-in loss tends to come back within a year. Because tirzepatide fades over a shorter window than semaglutide, using that time to lock in protein, strength training, sleep, and movement matters even more. Regain is a predictable physiological rebound, not a verdict on you, and the plan you set now is what shapes how the year unfolds.